“晟德”米瑞液 0.8毫克/毫升 (布他米雷特)
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Patient Information leaflet
(PIL)
04-06-2020
Public Assessment Report
(PAR)
27-03-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
BUTAMIRATE CITRATE
Available from:
晟德大藥廠股份有限公司 台北市南港區園區街3之2號7樓 (18606304)
ATC code:
R05DB13
Pharmaceutical form:
內服液劑
Composition:
BUTAMIRATE CITRATE (4800000410) MG
Units in package:
塑膠瓶裝
Class:
製 劑
Prescription type:
須由醫師處方使用
Manufactured by:
晟德大藥廠股份有限公司新竹廠 新竹縣湖口鄉實踐路2號 TW
Therapeutic area:
butamirate
Therapeutic indications:
鎮咳 (感冒、支氣管炎、氣喘性支氣管炎所引起之咳嗽)。
Product summary:
有效日期: 2027/08/09; 英文品名: Mirate Liquid 0.8 mg/ml (Butamirate Citrate) “Center”
Authorization date:
2007-08-09
Patient Information leaflet
130.00 mm
150.00 mm
130.00 mm
150.00 mm
Read the complete document
